After initially showing a lack of direction, stocks have moved mostly lower over the course of the trading day on Friday. The losses on the day are partly offsetting the strong move to the upside that was seen in the previous session.
Biotechnology stocks have shown a notable move to the downside on the day, dragging the NYSE Arca Biotechnology Index down by 1.3 percent.
Myriad Genetics (MYGN) is leading the biotech sector lower, falling by 7 after yesterday's Supreme Court ruling rejecting patents on naturally-occurring human genes.
Brokerage and banking stocks are also seeing significant weakness, with the NYSE Arca Broker/Dealer Index and the KBW Bank Index both falling by 1.1 percent.
Most of the other major sectors have also moved lower over the course of the session, although selling pressure has remained relatively subdued.
The major averages have climbed off their lows for the session in recent trading but remain firmly in the red. The Dow is down 70.69 points or 0.5 percent at 15,105.39, the Nasdaq is down 16.00 points or 0.5 percent at 3,429.37 and the S&P 500 is down 6.44 points or 0.4 percent at 1,629.92.
For comments and feedback contact: editorial@rttnews.com
Market Analysis
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.